Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
123
-
Total 13F shares, excl. options
-
24.2M
-
Shares change
-
+2.06M
-
Total reported value, excl. options
-
$967M
-
Value change
-
+$97.2M
-
Put/Call ratio
-
0.53
-
Number of buys
-
58
-
Number of sells
-
-55
-
Price
-
$39.89
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q4 2020
141 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q4 2020.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.2M shares
of 48M outstanding shares and own 50.44% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (7.44M shares), WASATCH ADVISORS INC (1.34M shares), VANGUARD GROUP INC (1.28M shares), BlackRock Inc. (1.23M shares), MARSHALL WACE, LLP (1.16M shares), Ranger Investment Management, L.P. (990K shares), AMERIPRISE FINANCIAL INC (917K shares), ROYCE & ASSOCIATES LP (845K shares), Russell Investments Group, Ltd. (841K shares), and TimesSquare Capital Management, LLC (516K shares).
This table shows the top 123 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.